Z Foldvari, C Knetter, W Yang, TJ Gjerdingen… - npj Vaccines, 2023 - nature.com
Cancer immunotherapy using T cell receptor-engineered T cells (TCR-Ts) represents a
promising treatment option. However, technologies for pre-clinical safety assessment are …